院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL...

20

Transcript of 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL...

Page 1: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 2: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 3: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 4: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 5: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 6: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 7: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 8: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 9: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 10: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 11: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 12: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 13: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 14: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 15: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 16: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 17: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 18: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 19: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg
Page 20: 院内検査項目・基準値一覧 第3版...mg/ dl- mg/ d L mg/ dl- mg/ g. Cr mg/ dl- mg/dL mg/dL mmol/L mmol/L mmol/L mg/ dl- mg/dL IU/L IU/L mg/dL mg/dL mOsm/kg H20 mg/ day mg

Adaptation in brain glucose uptakefollowing ...Proc. Natl. Acad. Sci. USA91 (1994) 9353 5-7 mintoguide dextroseadjustments. Arterialglucosewas decreasedby0.56 mmol/liter(10 mg/dl)every60-80minto

Adaptation in brain glucose uptakefollowing ...Proc. Natl. Acad. Sci. USA91 (1994) 9353 5-7 mintoguide dextroseadjustments. Arterialglucosewas decreasedby0.56 mmol/liter(10 mg/dl)every60-80minto

Definition, Klassifikation, Ätiologie, Diagnose und DD ......2020/08/31  · 3.05 – 5,55 mmol/l (54,9 – 100 mg/dl)konstant gehalten Blutzuckeranstieg bei massiver Kohlenhydratzufuhr

Definition, Klassifikation, Ätiologie, Diagnose und DD ......2020/08/31  · 3.05 – 5,55 mmol/l (54,9 – 100 mg/dl)konstant gehalten Blutzuckeranstieg bei massiver Kohlenhydratzufuhr

DM2 Criteria for the Diagnosis of Diabetes A1C ≥6.5% OR Fasting plasma glucose (FPG) ≥126 mg/dl (7.0 mmol/l) OR Two-hour plasma glucose ≥200 mg/dl (11.1.

DM2 Criteria for the Diagnosis of Diabetes A1C ≥6.5% OR Fasting plasma glucose (FPG) ≥126 mg/dl (7.0 mmol/l) OR Two-hour plasma glucose ≥200 mg/dl (11.1.

 · 2020. 12. 24. · pC02 pC02 p02 p02 Na Cl- iCa iCa Glu Glu Lac Lac Product Description CONTROL 3 min -x- max nmol/L mmHg kPa mmHg kPa mmol/L mmol/L mmol/L mmol/L mg/dL mg/dL mmol/L

 · 2020. 12. 24. · pC02 pC02 p02 p02 Na Cl- iCa iCa Glu Glu Lac Lac Product Description CONTROL 3 min -x- max nmol/L mmHg kPa mmHg kPa mmol/L mmol/L mmol/L mmol/L mg/dL mg/dL mmol/L

Magnesium C CPZ - Wiener lab · 2019. 12. 9. · de referencia: Suero o plasma: 1,6 a 2,6 mg/dl (0,66 a 1,07 mmol/l) Orina: 3,0 a 5,0 mmol/24 hs Cada laboratorio debe establecer sus

Magnesium C CPZ - Wiener lab · 2019. 12. 9. · de referencia: Suero o plasma: 1,6 a 2,6 mg/dl (0,66 a 1,07 mmol/l) Orina: 3,0 a 5,0 mmol/24 hs Cada laboratorio debe establecer sus

Standards of Medical Care in Diabetes · IGT 2-h plasma glucose 140 mg/dl (7.8 mmol/l) to 199 mg/dl (11.0 mmol/l) Recently, IFG and IGT have been offi-cially termed “pre-diabetes.”

Standards of Medical Care in Diabetes · IGT 2-h plasma glucose 140 mg/dl (7.8 mmol/l) to 199 mg/dl (11.0 mmol/l) Recently, IFG and IGT have been offi-cially termed “pre-diabetes.”

64 Lampiran Ethical Clearance - core.ac.uk · B e ra t T ida k 23 La k i'C'la k i 10,7 15600 3,1 ... Leukosit (sel/mm3) Albumin (gr/dl) Kreatinin (mg/dl) Natrium (mmol/L) Kalium (mmol/L)

64 Lampiran Ethical Clearance - core.ac.uk · B e ra t T ida k 23 La k i'C'la k i 10,7 15600 3,1 ... Leukosit (sel/mm3) Albumin (gr/dl) Kreatinin (mg/dl) Natrium (mmol/L) Kalium (mmol/L)

ΑΙΜΑΤΟΛΟΓΙΚΑ ΝΟΣΗΜΑΤΑ και ΝΕΦΡΟΣ...of normal or > 2.75 mmol/L (> 11 mg/dL) o Renal insufficiency: Creatinine Clearance

ΑΙΜΑΤΟΛΟΓΙΚΑ ΝΟΣΗΜΑΤΑ και ΝΕΦΡΟΣ...of normal or > 2.75 mmol/L (> 11 mg/dL) o Renal insufficiency: Creatinine Clearance

1 8 ·  · 2014-09-16(profil Brod) byla vletech 2011 ... [6] a doporučeným ... mg/l mg/l mg/l mg/l mg/l mg/l mmol/l mmol/l Dešťový odtok 15 80 3 0.5 160 1 0,4 7,4 0,43

1 8 ·  · 2014-09-16(profil Brod) byla vletech 2011 ... [6] a doporučeným ... mg/l mg/l mg/l mg/l mg/l mg/l mmol/l mmol/l Dešťový odtok 15 80 3 0.5 160 1 0,4 7,4 0,43

Facile “Click” to Fabricate a FRET-Based · 2014. 4. 29. · A slurry of 3 (100 mg, 0.20 mmol), 4 (35 mg, 0.20 mmol), CuI (3.8 mg, 0.02 mmol ) and N,N-diisopropylethylamine (26

Facile “Click” to Fabricate a FRET-Based · 2014. 4. 29. · A slurry of 3 (100 mg, 0.20 mmol), 4 (35 mg, 0.20 mmol), CuI (3.8 mg, 0.02 mmol ) and N,N-diisopropylethylamine (26

Clinical aspects of common mineral disorders. hypocalcemia Normal [Ca2+] total = 8.5-10.5 mg/dl (2.12-2.62 mmol/L) Normal [Ca2+] ion = 4.65-5.25 mg/dL.

Clinical aspects of common mineral disorders. hypocalcemia Normal [Ca2+] total = 8.5-10.5 mg/dl (2.12-2.62 mmol/L) Normal [Ca2+] ion = 4.65-5.25 mg/dL.

...iCa iCa Glu Glu Lac Lac EN Product Description CONTROL 3 min -x - max nmol/L mmHg kPa mmHg kPa mmol/L mmol/L mmol/L mmol/L mg/dL mg/dL mmol/L mmol/L m Idl- CONTROL 1 CONTROL 2 min

...iCa iCa Glu Glu Lac Lac EN Product Description CONTROL 3 min -x - max nmol/L mmHg kPa mmHg kPa mmol/L mmol/L mmol/L mmol/L mg/dL mg/dL mmol/L mmol/L m Idl- CONTROL 1 CONTROL 2 min

Cleveland Chiropractic Homecoming 2019€¦ · • Normal blood sugar range for a healthy person is about 83 mg/dl (4.6 mmol/L) to 120 mg/dl (6.6 mmol/L). • Glucose levels fluctuate

Cleveland Chiropractic Homecoming 2019€¦ · • Normal blood sugar range for a healthy person is about 83 mg/dl (4.6 mmol/L) to 120 mg/dl (6.6 mmol/L). • Glucose levels fluctuate

Electronic Supplementary Information · The mixture of commercial benzyl alcohol 1a (0.93 mL, 9 mmol), phenylacetone 6a (360.5 mg, 3 mmol), Cu(OAc)2.H2O (6 mg, 0.03 mmol, 1 mol%)

Electronic Supplementary Information · The mixture of commercial benzyl alcohol 1a (0.93 mL, 9 mmol), phenylacetone 6a (360.5 mg, 3 mmol), Cu(OAc)2.H2O (6 mg, 0.03 mmol, 1 mol%)

Contentsdibromofluorenone (1) (159 mg, 0.47 mmol), aniline hydrochloride (172 mg, 1.33 . S4 mmol), aniline (2 mL, 21.47 mmol)MHz,were heated at 135 oC for 24 h. After cooling to room

Contentsdibromofluorenone (1) (159 mg, 0.47 mmol), aniline hydrochloride (172 mg, 1.33 . S4 mmol), aniline (2 mL, 21.47 mmol)MHz,were heated at 135 oC for 24 h. After cooling to room

Non-fasting lipid profiles: implications for lipoprotein ...eflm.eu/files/efcc/EFLM_webinar_non-fasting_lipids_42016_handouts… · § 175 - 880 mg/dl (2 - 10 mmol/l) § non-HDLC

Non-fasting lipid profiles: implications for lipoprotein ...eflm.eu/files/efcc/EFLM_webinar_non-fasting_lipids_42016_handouts… · § 175 - 880 mg/dl (2 - 10 mmol/l) § non-HDLC

Liverpool Hope University - Buch…  · Web view) define a borderline high range for triglyceride concentrations as 90-129 mg/dL (1.02-1.46 mmol/L). Thus, 1.24 mmol/L was used as

Liverpool Hope University - Buch…  · Web view) define a borderline high range for triglyceride concentrations as 90-129 mg/dL (1.02-1.46 mmol/L). Thus, 1.24 mmol/L was used as

Supplementary Online Content...defined on the basis of a fasting glucose level ≥7.0 mmol/L (≥126 mg/dL), or non-fasting plasma glucose levels ≥11.1 mmol/L (≥200 mg/dL) if fasting

Supplementary Online Content...defined on the basis of a fasting glucose level ≥7.0 mmol/L (≥126 mg/dL), or non-fasting plasma glucose levels ≥11.1 mmol/L (≥200 mg/dL) if fasting

Diabetes Across the Lifespan Across a Lifespan_John An… · 1. IFG- FPG 100-125 mg/dl (5.6- 6.9 mmol/l) 2. IGT - 140- 199 mg/dl (7.8-11.0 mmol/l) 2-h post 75-g OGTT 3. A1C 5.5–6.4%

Diabetes Across the Lifespan Across a Lifespan_John An… · 1. IFG- FPG 100-125 mg/dl (5.6- 6.9 mmol/l) 2. IGT - 140- 199 mg/dl (7.8-11.0 mmol/l) 2-h post 75-g OGTT 3. A1C 5.5–6.4%

ku€¦ · high-density lipoprotein cholesterol levels (HDL-C: ≤40 mg/dl; 1.03 mmol/l) to either pemafibrate (0.2 mg twice daily) or matching placebo with an average expected follow-up

ku€¦ · high-density lipoprotein cholesterol levels (HDL-C: ≤40 mg/dl; 1.03 mmol/l) to either pemafibrate (0.2 mg twice daily) or matching placebo with an average expected follow-up